Your browser doesn't support javascript.
loading
2 L versus 4 L of PEG3350 + electrolytes for outpatient colonic preparation: a randomized, controlled trial.
Brahmania, Mayur; Ou, George; Bressler, Brian; Ko, Hin Kin; Lam, Eric; Telford, Jennifer; Enns, Robert.
Afiliação
  • Brahmania M; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ou G; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bressler B; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ko HK; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Lam E; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Telford J; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Enns R; Division of Gastroenterology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Gastrointest Endosc ; 79(3): 408-416.e4, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24206747
ABSTRACT

BACKGROUND:

Low-volume bowel preparations are ideal to ensure patient compliance, thus enabling high-quality examinations to be achieved.

OBJECTIVES:

To examine the bowel-cleansing efficacy and patient tolerability of split-dose 2 L PEG3350 + electrolytes (PEG3350e) with 15 mg bisacodyl versus split-dose 4 L PEG3350e.

DESIGN:

Single-blinded, noninferiority, randomized, controlled trial.

SETTING:

Single site, university-affiliated tertiary care center. PATIENTS A total of 325 consecutive patients undergoing elective outpatient colonoscopy. INTERVENTION 2 L of PEG3350e with 15 mg bisacodyl versus 4 L of PEG3350e, both given in a split-dose fashion. MAIN OUTCOME MEASUREMENTS Efficacy and tolerability of a split dose of 2 L of PEG3350e with 15 mg bisacodyl. Efficacy was assessed by using the Boston Bowel Preparation Scale and Ottawa Bowel Preparation Scale. Patient satisfaction and tolerability were assessed by using a short survey.

RESULTS:

A total of 325 patients were included in the intention-to-treat analysis (51% male) with a mean ± standard deviation age of 56 ± 11.2 years. No statistically significant difference in cleanliness was found by using the Boston Bowel Preparation Scale (intention-to-treat, P = .381; per-protocol, P = .387) and the Ottawa Bowel Preparation Scale (intention-to-treat, P = .285; per-protocol, P = .334). Participants receiving 2 L of PEG3350e found the preparation easy to consume and were willing to repeat the procedure more often than the 4-L group (P < .001).

LIMITATIONS:

Single-center study looking at outpatient colonoscopies; unable to comment on adenoma detection rate.

CONCLUSIONS:

Bowel-cleansing efficacy was similar in both the 2-L and 4-L PEG3350e groups; however, patient tolerability and willingness to repeat preparation were statistically greater with the 2 L of PEG3350e with 15 mg bisacodyl regimen.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Catárticos / Colonoscopia Tipo de estudo: Clinical_trials Limite: Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Catárticos / Colonoscopia Tipo de estudo: Clinical_trials Limite: Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article